Motif ID | Motif Logo | Scanned Score Distribution | Frequency of Motif | Replicability Score | Evolutionary Conservation Score | Gene Targets | Gene Ontology of CpGMM targets |
---|---|---|---|---|---|---|---|
CG_h1r2_promoter_p_RM_12_18_2 | ![]() |
![]() |
3 | 0.5 | 5.50E-04 | SIRT1, GNAS, ASXL1 | negative regulation of fat cell differentiation [BP], post-embryonic body morphogenesis [BP], negative regulation of cellular response to testosterone stimulus [BP], establishment of chromatin silencing [BP], regulation of peroxisome proliferator activated receptor signaling pathway [BP], negative regulation of cAMP-dependent protein kinase activity [BP], negative regulation of prostaglandin biosynthetic process [BP] |
CG_h1r2_promoter_p_RM_12_24_2 | ![]() |
![]() |
4 | 0.75 | 5.21E-04 | HMGA1, MAGI3, POLH, PDGFRA | DNA replication [BP], platelet-derived growth factor alpha-receptor activity [MF], virus-host interaction [BP] |
CG_h1r2_promoter_p_RM_12_23_2 | ![]() |
![]() |
1 | 0.25 | 1.30E-04 | GATA4, CMPK1 | lung lobe formation [BP], dCDP biosynthetic process [BP], CDP biosynthetic process [BP], UDP biosynthetic process [BP] |
CG_h1r2_promoter_p_RM_12_19_2 | ![]() |
![]() |
2 | 0.5 | 2.10E-04 | PNRC2 | deadenylation-independent decapping of nuclear-transcribed mRNA [BP] |
CG_h1r2_promoter_p_RM_12_25_4 | ![]() |
![]() |
4 | 0.75 | 1.56E-04 | CHAC1, ATP9B, HOXD3, RBPJ | cation-transporting ATPase activity [MF], Notch signaling pathway [BP] |
CG_h1r2_promoter_p_RM_12_28_4 | ![]() |
![]() |
2 | 0.5 | 9.89E-05 | SLC9A3R1, CRHR1, FN3K | renal phosphate ion absorption [BP], fructoselysine metabolic process [BP], corticotropin-releasing hormone receptor activity [MF], fructosamine-3-kinase activity [MF], phospholipase C-activating G-protein coupled receptor signaling pathway [BP], bile acid secretion [BP], adenylate cyclase-activating G-protein coupled receptor signaling pathway [BP] |
CG_h1r2_promoter_p_RM_12_26_4 | ![]() |
![]() |
4 | 0.75 | 2.49E-04 | NT5M | dUMP catabolic process [BP], pyrimidine nucleobase metabolic process [BP] |
CG_h1r2_promoter_p_RM_12_3_3 | ![]() |
![]() |
1 | 0.25 | 3.94E-05 | CHEK1, EID3 | histone kinase activity (H3-T11 specific) [MF], regulation of histone H3-K9 acetylation [BP], regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [BP], histone H3-T11 phosphorylation [BP], chromosome, telomeric region [CC] |
CG_h1r2_promoter_p_RM_12_29_2 | ![]() |
![]() |
4 | 0.75 | 1.96E-04 | MEIS1, ZBTB16 | negative regulation of myeloid cell differentiation [BP] |
CG_h1r2_promoter_p_RM_12_20_1 | ![]() |
![]() |
2 | 0.5 | 1.28E-04 | ACO1 | citrate hydro-lyase (cis-aconitate-forming) activity [MF], iron-responsive element binding [MF], aconitate hydratase activity [MF], isocitrate hydro-lyase (cis-aconitate-forming) activity [MF], response to iron(II) ion [BP] |
CG_h1r2_promoter_p_RM_12_11_2 | ![]() |
![]() |
1 | 0.25 | 9.45E-05 | HCK, C5AR2 | respiratory burst after phagocytosis [BP], C5a anaphylatoxin receptor activity [MF] |
CG_h1r2_promoter_p_RM_12_16_2 | ![]() |
![]() |
2 | 0.5 | 2.73E-04 | GPI, ADRA2A, CACNA1E | glucose-6-phosphate isomerase activity [MF], negative regulation of adrenergic receptor signaling pathway [BP], methylglyoxal biosynthetic process [BP], phospholipase C-activating adrenergic receptor signaling pathway [BP], regulation of insulin secretion involved in cellular response to glucose stimulus [BP], adenylate cyclase-inhibiting adrenergic receptor signaling pathway [BP], fear response [BP] |
CG_h1r2_promoter_p_RM_12_30_3 | ![]() |
![]() |
5 | 1.0 | 1.70E-04 | PVRL2 | virion attachment, binding of host cell surface coreceptor [BP] |
CG_h1r2_promoter_p_RM_12_31_1 | ![]() |
![]() |
3 | 0.75 | 7.65E-05 | ACTN4 | positive regulation of pinocytosis [BP] |
CG_h1r2_promoter_p_RM_12_5_2 | ![]() |
![]() |
1 | 0.25 | 1.67E-04 | MINPP1, HELT | inositol hexakisphosphate 2-phosphatase activity [MF], bisphosphoglycerate 3-phosphatase activity [MF], polyphosphate metabolic process [BP], GABAergic neuron differentiation in basal ganglia [BP] |
CG_h1r2_promoter_p_RM_12_17_2 | ![]() |
![]() |
3 | 0.75 | 1.19E-04 | PRKCG, IL17RC | positive regulation of mismatch repair [BP], negative regulation of protein ubiquitination [BP], interleukin-17 receptor activity [MF] |
CG_h1r2_promoter_p_RM_12_8_1 | ![]() |
![]() |
1 | 0.25 | 3.22E-05 | DNAJB2, B3GALT4 | positive regulation of protein ubiquitination [BP], negative regulation of inclusion body assembly [BP], ganglioside galactosyltransferase activity [MF], negative regulation of protein deubiquitination [BP] |
CG_h1r2_promoter_p_RM_12_10_3 | ![]() |
![]() |
2 | 0.5 | 2.06E-05 | SRP54 | SRP-dependent cotranslational protein targeting to membrane, translocation [BP], SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [BP] |
CG_h1r2_promoter_p_RM_12_6_2 | ![]() |
![]() |
1 | 0.25 | 4.49E-05 | DYNLL1, COPS4, CLYBL | citrate (pro-3S)-lyase activity [MF], signalosome [CC] |
CG_h1r2_promoter_p_RM_12_12_3 | ![]() |
![]() |
5 | 1.0 | 3.28E-04 | CHAC1, HOXD3, TLE4 | Notch signaling pathway [BP] |
CG_h1r2_promoter_p_RM_12_9_1 | ![]() |
![]() |
1 | 0.25 | 7.24E-05 | ABCB5, ERCC5 | nucleotide-excision repair, DNA incision, 3'-to lesion [BP], bubble DNA binding [MF], efflux transmembrane transporter activity [MF] |
CG_h1r2_promoter_p_RM_12_13_2 | ![]() |
![]() |
3 | 0.75 | 1.13E-04 | SHMT2, HSD11B1, STAT5A | L-allo-threonine aldolase activity [MF], glycine biosynthetic process from serine [BP], 11-beta-hydroxysteroid dehydrogenase (NADP+) activity [MF], glycine hydroxymethyltransferase activity [MF], positive regulation of mast cell differentiation [BP], 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF] |
CG_h1r2_promoter_p_RM_12_4_3 | ![]() |
![]() |
1 | 0.25 | 5.07E-05 | MUC2 | inner mucus layer [CC], outer mucus layer [CC] |
CG_h1r2_promoter_p_RM_12_32_2 | ![]() |
![]() |
2 | 0.5 | 3.12E-04 | STK16, BMX | non-membrane spanning protein tyrosine kinase activity [MF] |
CG_h1r2_promoter_p_RM_12_14_3 | ![]() |
![]() |
5 | 1.0 | 3.44E-04 | ADRB2, FZD7, PTPN6, IL17C, LPHN2 | beta2-adrenergic receptor activity [MF], negative regulation of ectodermal cell fate specification [BP], G-protein coupled receptor signaling pathway [BP], cell surface receptor signaling pathway [BP] |
CG_h1r2_promoter_p_RM_12_15_3 | ![]() |
![]() |
2 | 0.5 | 2.17E-05 | THTPA | thiamin-triphosphatase activity [MF] |